|
Volumn 1, Issue 6, 2015, Pages 729-730
|
Having skin in the game and allowing cross-border importation of drugs to lower high prices of cancer drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GENERIC DRUG;
CANADA;
COMMERCIAL PHENOMENA;
DRUG COST;
DRUG INDUSTRY;
ECONOMICS;
HEALTH CARE DELIVERY;
HEALTH CARE DISPARITY;
HUMAN;
NEOPLASMS;
PATENT;
SUPPLY AND DISTRIBUTION;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
CANADA;
COMMERCE;
DRUG COSTS;
DRUG INDUSTRY;
DRUGS, GENERIC;
HEALTH SERVICES ACCESSIBILITY;
HEALTHCARE DISPARITIES;
HUMANS;
NEOPLASMS;
PATENTS AS TOPIC;
UNITED STATES;
|
EID: 85010877165
PISSN: 23742437
EISSN: 23742445
Source Type: Journal
DOI: 10.1001/jamaoncol.2015.1024 Document Type: Note |
Times cited : (17)
|
References (7)
|